SCHEMBL19032873

SCHEMBL19032873

O=c1c(-c2cccc([N+](=O)[O-])c2)nc2cc(F)c(F)cc2n1Cc1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 19/20 0.79
▸ PGR P06401 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19032882 0.90 CFTR (0.80) CFTRPGR
SCHEMBL19032762 0.89 CFTR (0.77) CFTRPGR
SCHEMBL19032793 0.88 CFTR (1.00) CFTR
SCHEMBL19032877 0.87 CFTR (1.00) CFTR
SCHEMBL19032881 0.87 CFTR (1.00) CFTR
SCHEMBL19032732 0.86 CFTR (0.85) CFTR
SCHEMBL19032883 0.86 CFTR (1.00) CFTR
SCHEMBL19032867 0.81 CFTR (1.00) CFTRPGR
SCHEMBL19032884 0.80 CFTR (0.74) CFTR
SCHEMBL19032872 0.78 CFTR (1.00) CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503447-B2 CFTR regulators and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-12-23 — — US disclosed
US-20210347742-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-11-11 — — US disclosed
US-11084795-B2 CFTR regulators and methods of use thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-08-10 — — US disclosed
CN-108699040-B Modulators of CFTR and methods of use thereof 加利福尼亚大学董事会 2021-08-10 — — CN disclosed
US-20190031622-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2019-01-31 — — US disclosed
EP-3394046-A1 CFTR REGULATORS AND METHODS OF USE THEREOF The Regents of the University of California, A California Corporation (US) 2018-10-31 — — EP disclosed
WO-2017112950-A1 CFTR REGULATORS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190031622-A1 CFTR REGULATORS AND METHODS OF USE THEREOF CFTR, SLC26A4, CLCN2 CFTR 1/4885PGR 3474/4885
US-20210347742-A1 CFTR REGULATORS AND METHODS OF USE THEREOF CFTR, SLC26A4, CLCN2 CFTR 1/4885PGR 3474/4885
US-11084795-B2 CFTR regulators and methods of use thereof CFTR, SLC26A4, CLCN2 CFTR 1/4885PGR 3474/4885
US-12503447-B2 CFTR regulators and methods of use thereof CFTR, SLC26A4, CLCN2 CFTR 1/4885PGR 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback